Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,022 GBX | +0.39% | +1.29% | -5.38% |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.38% | 11.17B | A- | ||
+9.53% | 124B | A- | ||
+4.83% | 9.17B | C | ||
-23.02% | 4.71B | C | ||
+8.71% | 3.44B | C- | ||
-5.40% | 2.88B | B- | ||
-12.05% | 2.11B | - | - | |
-7.83% | 2.09B | - | ||
-22.62% | 1.8B | - | C- | |
-8.33% | 1.17B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SN. Stock
- Ratings Smith & Nephew Plc